Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-to-commence-the-next-generation-clinical-trials-of-car-t-cell-therapy-for-haematological-malignancy
https://www.med.cuhk.edu.hk/press-releases/cuhk-to-commence-the-next-generation-clinical-trials-of-car-t-cell-therapy-for-haematological-malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

The Chinese University of Hong Kong (CUHK) will commence clinical trials of Chimeric antigen receptor-T cell (CAR-T cell) therapy, with the first phase targeting patients with haematological malignancy. The plan is to increase the survival rate and prolong overall survival for these patients. To accomplish this goal, CUHK is planning to establish Hong Kong’s first CAR-T cell laboratory licensed with Good Manufacturing Practice (GMP). It is expected to complete construction in 2020 and start clinical trials once the GMP licence is obtained. The research team hopes the therapy can further cover patients with other cancer types in the future.

 

CUHK will commence clinical trials of CAR-T cell therapy, with the first phase targeting patients with haematological malignancy. The plan is to increase the survival rate and prolong overall survival for these patients.

CUHK will commence clinical trials of CAR-T cell therapy, with the first phase targeting patients with haematological malignancy. The plan is to increase the survival rate and prolong overall survival for these patients.

CAR-T cell therapy builds radar on immune cells to detect cancer cells and launch attack

 

Cancer is the number one killer in Hong Kong. Haematological malignancy, including leukemia and lymphoma, counts as one of the top ten cancers in mortality. There is an average of 2,000 new cases each year in Hong Kong. Half are under the age of 65 and many of them are children and young patients.

Chemotherapy is the conventional treatment of haematological malignancy, with a cure rate ranging from 30% to 80%. However, it carries side effects and complications as normal cells are also damaged in the process. When chemotherapy fails, haematopoietic stem cell transplant serves as salvage therapy where 30% to 60% of patients can be cured. However, complications can also be significant.

 

Professor Anthony Tak Cheung CHAN, Li Shu Fan Professor of Clinical Oncology, Faculty of Medicine at CUHK and Director of Sir YK Pao Centre for Cancer at the Hong Kong Cancer Institute, remarked, “Cancer treatment can be difficult when cancer cells mutate and become refractory. Patients often have to seek a new treatment after a while and therefore it is crucial to find a therapy that can achieve long-term efficacy as well as fewer side effects.”

 

Immunotherapy has been a hot topic in cancer treatment in recent years. It helps enhance patient’s immune system to clear cancer cells.  Among all, cellular therapy utilises patient’s own immune cells to tackle cancer cells. A patient’s immune cells are genetically manipulated so as to recognise the cancer cells and exert a killing effect. Patients under this therapy may achieve long term survival. CAR-T cell therapy is one of these types.

 

Professor Margaret Heung Ling NG, Professor of the Department of Anatomical and Cellular Pathology, Faculty of Medicine at CUHK, explained, “To conduct CAR-T cell therapy, we first have to extract T cells from patient’s blood. T cells are the cells of the immune system that fight infections and can kill cancer cells in the right circumstances. But some of the cancers can evade the immune system. Upon taking the patient’s T cells, we modify them in a qualified laboratory and build in radar-like receptors on the cells, allowing them to recognise and attack cancer cells after being reinfused into the patient’s body.”

 

Professor LI Chi Kong, Professor of the Department of Paediatrics, Faculty of Medicine at CUHK, added, “CAR-T cell therapy helps patients fight cancers with their own immune system. Since the modified T cells are targeting specifically the cancer cells with the receptors, the therapy reduces the harm to normal cells. The therapy will help patients maintain in vivo anti-cancer activity and thus prolong overall survival.”

 

Professor Anthony CHAN, Li Shu Fan Professor of Clinical Oncology, Faculty of Medicine at CUHK, hopes that the CAR-T cell therapy can further cover patients with other cancer types in the future.

Professor Anthony CHAN, Li Shu Fan Professor of Clinical Oncology, Faculty of Medicine at CUHK, hopes that the CAR-T cell therapy can further cover patients with other cancer types in the future.

Professor LI Chi Kong, Professor of the Department of Paediatrics, Faculty of Medicine at CUHK, states that the CUHK is working on the preparation of CAR-T cell therapy clinical trial for child and adult patients with leukemia or lymphoma. The research team carries high hope that this next generation therapy will become available in Hong Kong.

Professor LI Chi Kong, Professor of the Department of Paediatrics, Faculty of Medicine at CUHK, states that the CUHK is working on the preparation of CAR-T cell therapy clinical trial for child and adult patients with leukemia or lymphoma. The research team carries high hope that this next generation therapy will become available in Hong Kong.

 

Facility construction expected to be completed in 2020 and attain GMP

 

CAR-T cell therapy requires a qualified “clean” laboratory to prepare the anti-cancer cells. The facility CUHK is planning to build will enable the special manipulation of T cells to happen, which includes “genetic modulation of cells” and “expansion of cells to adequate quantity and to achieve maximal killing of cancer cells”. The team will also train staff to specialise in handling the procedures. The design and structure of the facility will maintain the highest quality of safety and meet the GMP standard.

 

Dr. Daniel H.S. LEE, Associate Vice-President (Innovation and Enterprise) of CUHK remarked, “We will join hands with the Hong Kong Science and Technology Parks Corporation on the project, with the goal to complete construction in 2020 and officially conduct clinical trials once GMP is obtained. We believe this innovative development will provide more treatment choices to patients in Hong Kong and neighbouring regions.”  

 

Professor Margaret NG (right), Professor of the Department of Anatomical and Cellular Pathology of the Faculty of Medicine at CUHK, explains that in CAR-T cell therapy, a patient’s T cells are genetically modified to build in radar-like receptors on the cells. The T-cells can recognise and attack cancer cells after being reinfused into the patient’s body.

Professor Margaret NG (right), Professor of the Department of Anatomical and Cellular Pathology of the Faculty of Medicine at CUHK, explains that in CAR-T cell therapy, a patient’s T cells are genetically modified to build in radar-like receptors on the cells. The T-cells can recognise and attack cancer cells after being reinfused into the patient’s body.

Dr. Daniel LEE, Associate Vice-President (Innovation and Enterprise) of CUHK, states that construction of the qualified laboratory for CAR-T cell therapy is expected to be completed in 2020. Clinical trials will be launched once the GMP licence is obtained.

Dr. Daniel LEE, Associate Vice-President (Innovation and Enterprise) of CUHK, states that construction of the qualified laboratory for CAR-T cell therapy is expected to be completed in 2020. Clinical trials will be launched once the GMP licence is obtained.

To explore possibility of applying CAR-T cell therapy to other cancer types

 

Two types of CAR–T cell therapies are currently available in some overseas centres for patients with leukemia and lymphoma. Professor Li added, “CUHK is working day and night on the preparation of CAR-T cell therapy clinical trial for child and adult patients with leukemia or lymphoma. We carry high hope that this next generation therapy will become available in Hong Kong. Our another goal is to carry out clinical trials testing different types of CAR-T cell therapy for different types of cancers.”

More Press Releases

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

Research
A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

Research
CUHK unlocks the secret of cancer pain  Identifying a new therapeutic key to ending the sorrow

CUHK unlocks the secret of cancer pain Identifying a new therapeutic key to ending the sorrow

Research
CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

Research
CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

Research
CUHK Receives an International Cancer Care Team Award Nominated by Patients

CUHK Receives an International Cancer Care Team Award Nominated by Patients

Awards and honors
CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

Research
CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

Research
CUHK’s HK-HOPE develops an integrated drug and genomic test to tailor precision personalised medicine and deliver “hope” to children with difficult-to-treat leukaemia

CUHK’s HK-HOPE develops an integrated drug and genomic test to tailor precision personalised medicine and deliver “hope” to children with difficult-to-treat leukaemia

Research
CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

Research
CUHK leading Asia’s battle to improve bile duct cancer survival rates by developing a novel combinational strategy in clinical trial

CUHK leading Asia’s battle to improve bile duct cancer survival rates by developing a novel combinational strategy in clinical trial

Research
CUHK’s study sees a rising trend of multiple myeloma incidence,  particularly in older males from high-income countries

CUHK’s study sees a rising trend of multiple myeloma incidence, particularly in older males from high-income countries

Research
COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

Research
CUHK receives HK$150 million donation from Li Ka Shing Foundation in support of research and development of biomedical technologies

CUHK receives HK$150 million donation from Li Ka Shing Foundation in support of research and development of biomedical technologies

Donation
CUHK unveils the evolutionary history of medically important mites, laying the genomics groundwork for diagnosis of and intervention in mite allergy

CUHK unveils the evolutionary history of medically important mites, laying the genomics groundwork for diagnosis of and intervention in mite allergy

Research
CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

Research
Study by CUHK medical students identifies STK3 kinase as a driver in gastric cancer

Study by CUHK medical students identifies STK3 kinase as a driver in gastric cancer

Education
CU Medicine proves basophil activation test has much higher diagnostic accuracy  for shrimp allergy than conventional allergy tests

CU Medicine proves basophil activation test has much higher diagnostic accuracy for shrimp allergy than conventional allergy tests

Research
CU Medicine Study Shows Childhood Obstructive Sleep Apnoea Increases the Risk of Hypertension in Adulthood

CU Medicine Study Shows Childhood Obstructive Sleep Apnoea Increases the Risk of Hypertension in Adulthood

Research
CUHK Uncovers a New Strategy to Turn “Cold” Liver Tumour “Hot” Leading to an Effective and Durable Combined Immunotherapy

CUHK Uncovers a New Strategy to Turn “Cold” Liver Tumour “Hot” Leading to an Effective and Durable Combined Immunotherapy

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
CU Medicine Studies Suggest Grass Carp as a Major Source of Fish Allergy in Hong Kong And Identify Novel Allergenic Marker Cten i 1 to Promote Accurate Diagnosis

CU Medicine Studies Suggest Grass Carp as a Major Source of Fish Allergy in Hong Kong And Identify Novel Allergenic Marker Cten i 1 to Promote Accurate Diagnosis

Research
CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

Research
CUHK Uncovers How Immune Cells Turn Bad A New Hope for Kidney Patients

CUHK Uncovers How Immune Cells Turn Bad A New Hope for Kidney Patients

Research
Professor Tony Mok Recognised as a Giant of Cancer Care  for His Remarkable Contribution in Advancing Global Healthcare in Lung Cancer

Professor Tony Mok Recognised as a Giant of Cancer Care for His Remarkable Contribution in Advancing Global Healthcare in Lung Cancer

Awards and honors
Insights into B-cells and GPR18 Gene Expression by CU Medicine team  Improve Prediction of Survival in Multiple Cancer Types

Insights into B-cells and GPR18 Gene Expression by CU Medicine team Improve Prediction of Survival in Multiple Cancer Types

Research
CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

Research
CUHK Study Sees the Exposure to Farm Environment  Is Beneficial for Children to Prevent Asthma

CUHK Study Sees the Exposure to Farm Environment Is Beneficial for Children to Prevent Asthma

Research
CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

Surgical advancement
CUHK-Designed Intervention Package Proves Effective to Increase Influenza Vaccine Uptake in Hong Kong Young Children

CUHK-Designed Intervention Package Proves Effective to Increase Influenza Vaccine Uptake in Hong Kong Young Children

Research
李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

Donation
CUHK Establishes Hong Kong Hub of Paediatric Excellence (HK HOPE) Multidisciplinary Efforts Across the Globe to Advance Children’s Health and Well-being

CUHK Establishes Hong Kong Hub of Paediatric Excellence (HK HOPE) Multidisciplinary Efforts Across the Globe to Advance Children’s Health and Well-being

Health Campaign
Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Awards and honors
CUHK Study Sees Shorter Sleep Put Adolescents at Risk of Future Cardiovascular Diseases

CUHK Study Sees Shorter Sleep Put Adolescents at Risk of Future Cardiovascular Diseases

Research
CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

Health Campaign
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

Surgical advancement
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

Research
CUHK Proves Rotavirus Vaccine Highly Effective for HK Children

CUHK Proves Rotavirus Vaccine Highly Effective for HK Children

Research
CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

Research
CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

Donation
CUHK Unveils Genome of Dermatophagoides farinae Casting New Light on Diagnosis and Interventions of Inhalant Allergies

CUHK Unveils Genome of Dermatophagoides farinae Casting New Light on Diagnosis and Interventions of Inhalant Allergies

Research
The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

Symposium
CUHK Joint Research Sets a New Global Direction for Lung Cancer Treatment Molecular Targeted Therapy Proved more Effective in Treating Patients with ALK-Positive Lung Cancer

CUHK Joint Research Sets a New Global Direction for Lung Cancer Treatment Molecular Targeted Therapy Proved more Effective in Treating Patients with ALK-Positive Lung Cancer

Research
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Opens Phase I Clinical Trial Centre To Step Up New Drug Development in Hong Kong

CUHK Opens Phase I Clinical Trial Centre To Step Up New Drug Development in Hong Kong

Research
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research
CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

Symposium
CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

Surgical advancement
Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Surgical advancement
CUHK Proves a Non-invasive Technology Can Successfully Cure Cerebral Arteriovenous Malformation

CUHK Proves a Non-invasive Technology Can Successfully Cure Cerebral Arteriovenous Malformation

Clinical service
CUHK Launches Territory-wide Sleep Health Education Campaign to Promote Healthy Sleep and Healthy School Life

CUHK Launches Territory-wide Sleep Health Education Campaign to Promote Healthy Sleep and Healthy School Life

Health Campaign
CUHK Pioneers MRI Iron Assessment for Thalassemia Children in Southern China

CUHK Pioneers MRI Iron Assessment for Thalassemia Children in Southern China

Clinical service
CUHK Discovers the Environmental Factors in Family and School Behind Constipation in HK Children

CUHK Discovers the Environmental Factors in Family and School Behind Constipation in HK Children

Research
The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

Symposium
Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Clinical service

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.